H.R. 6227 — Introduced in House

I 118th CONGRESS 1st Session H. R. 6227 IN THE HOUSE OF REPRESENTATIVES November 3, 2023Mr. Schweikert (for himself, Mr. McCarthy, Mr. Burgess, Mr. Self, Mr. Ciscomani, Mr. Armstrong, Mr. Gallego, Ms. Caraveo, Mr. Costa, Mr. Grijalva, Mrs. Steel, Mr. Levin, Ms. De La Cruz, and Mr. Valadao) introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis. 1. Short title This Act may be cited as the Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023. 2. Expanding tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis Section 524(a)(3) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360n(a)(3)) is amended— (1) by redesignating subparagraph (S) as subparagraph (T); and (2) by inserting after subparagraph (R) the following: (S) Coccidioidomycosis. .